Halozyme Therapeutics (HALO) EPS (Diluted) (2010 - 2026)
Halozyme Therapeutics (HALO) posted EPS (Diluted) of $1.90 for Q2 2026, up 42.6% from $1.33 a year earlier and up 55.3% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EPS (Diluted) (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Halozyme Therapeutics was $3.41, down 24.0% year-over-year; for FY2025, it was $2.56, down 25.5% from FY2024.
- Annual EPS (Diluted) shows a five-year compound annual growth rate of 22.9% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' EPS (Diluted) was $3.43 in FY2024 (+63.5%), $2.10 in FY2023 (+46.0%), $1.44 in FY2022 (-47.6%) and $2.74 in FY2021 (+200.6%).
- The Q2 2026 figure stands as the highest quarterly EPS (Diluted) in data going back to Q2 2010.
- The strongest year-over-year quarter for EPS (Diluted) in the past five years was Q3 2021, with growth of 479.4%; the weakest was Q2 2022, with a decline of 74.3%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was $1.22 (Q1 2026), -$1.14 (Q4 2025) and $1.43 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 4.31 |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 1.90 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.90 |
| Mar 31, 2026 | 1.22 |
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | 1.43 |
| Jun 30, 2025 | 1.33 |
| Mar 31, 2025 | 0.93 |
| Dec 31, 2024 | 1.06 |
| Sep 30, 2024 | 1.05 |
| Jun 30, 2024 | 0.72 |
| Mar 31, 2024 | 0.60 |
| Dec 31, 2023 | 0.64 |
| Sep 30, 2023 | 0.61 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.44 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.43 |
| Dec 31, 2021 | 0.45 |
| Sep 30, 2021 | 1.48 |
API Access
Halozyme Therapeutics EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();